Business · 16/01/2020
FDA Releases Draft Guidance on Pediatric Study Plans for Oncology Drugs
The FDA has announced the availability of a draft guidance document addressing questions and answers about pediatric study plans for oncology drugs, in response to industry inquiries following the 2017 FDA Reauthorization Act.